We employed a mouse model of human RCC bone metastasis, and identified downregulation of HAI-2 and increased phosphorylation of MET with upregulation of HGF and matriptase in bone metastasis, suggesting enhanced ligand-dependent MET activation in an autocrine manner. The gene discussed is HGF; the disease is renal cell carcinoma.